These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10979783)

  • 1. Bone marrow metastases in breast cancer.
    Pikarsky E; Peretz T
    N Engl J Med; 2000 Aug; 343(8):577-8. PubMed ID: 10979783
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone marrow metastases in breast cancer.
    Diaz-Cano SJ
    N Engl J Med; 2000 Aug; 343(8):577; author reply 578. PubMed ID: 10979781
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone marrow metastases in breast cancer.
    Funke I; Schraut W
    N Engl J Med; 2000 Aug; 343(8):577; author reply 578. PubMed ID: 10979782
    [No Abstract]   [Full Text] [Related]  

  • 4. Approaches to breast-cancer staging.
    Smith BL
    N Engl J Med; 2000 Feb; 342(8):580-1. PubMed ID: 10684918
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiogenesis in the bone marrow of patients with breast cancer.
    Chavez-Macgregor M; Aviles-Salas A; Green D; Fuentes-Alburo A; Gómez-Ruiz C; Aguayo A
    Clin Cancer Res; 2005 Aug; 11(15):5396-400. PubMed ID: 16061853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated tumor cells in bone marrow and its relation with known prognostic factors in breast cancer patients.
    Sánchez R; González L; Betancourt L; Rodríguez JJ; Sánchez A; Spinetti D; Parada D; Melone S
    Breast J; 2009; 15(2):212-3. PubMed ID: 19292815
    [No Abstract]   [Full Text] [Related]  

  • 7. The clinical significance of disseminated tumor cells in breast cancer.
    Slade MJ; Coombes RC
    Nat Clin Pract Oncol; 2007 Jan; 4(1):30-41. PubMed ID: 17183354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
    Braun S; Pantel K; Müller P; Janni W; Hepp F; Kentenich CR; Gastroph S; Wischnik A; Dimpfl T; Kindermann G; Riethmüller G; Schlimok G
    N Engl J Med; 2000 Feb; 342(8):525-33. PubMed ID: 10684910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated tumor cells in bone marrow of early-stage breast cancer patients.
    Singletary SE
    J Am Coll Surg; 2006 Aug; 203(2):240-9; quiz A58-9. PubMed ID: 16864036
    [No Abstract]   [Full Text] [Related]  

  • 10. Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
    Lang JE; Hall CS; Singh B; Lucci A
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1463-72. PubMed ID: 17944570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.
    Benoy IH; Salgado R; Elst H; Van Dam P; Weyler J; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
    Breast Cancer Res; 2005; 7(2):R210-9. PubMed ID: 15743502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The "microscopic" revolution in breast carcinoma.
    Cristofanilli M
    Cancer; 2005 Mar; 103(5):877-80. PubMed ID: 15611972
    [No Abstract]   [Full Text] [Related]  

  • 13. Rating of isolated disseminated tumor cells in bone marrow in comparison with other factors of prognosis in breast carcinoma.
    Leinung S; Würl P; Schönfelder A; Weiss CL; Röder I; Schönfelder M
    Int J Surg Investig; 2000; 2(3):193-202. PubMed ID: 12678519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histological tumor type and bone marrow metastases of cancers of the breast].
    Soudah B; Stauch G; Spindler B; Nicolai U; Georgii A
    Verh Dtsch Ges Pathol; 1985; 69():338-41. PubMed ID: 4096114
    [No Abstract]   [Full Text] [Related]  

  • 15. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
    Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and clinical implications of early systemic tumor cell dissemination in breast cancer.
    Pantel K; Müller V; Auer M; Nusser N; Harbeck N; Braun S
    Clin Cancer Res; 2003 Dec; 9(17):6326-34. PubMed ID: 14695131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
    Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
    Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.
    Balic M; Lin H; Young L; Hawes D; Giuliano A; McNamara G; Datar RH; Cote RJ
    Clin Cancer Res; 2006 Oct; 12(19):5615-21. PubMed ID: 17020963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated cytokeratin positive tumor cells in the bone marrow of patients with prostate cancer: detection and prognostic value.
    Weckermann D; Müller P; Wawroschek F; Harzmann R; Riethmüller G; Schlimok G
    J Urol; 2001 Aug; 166(2):699-703. PubMed ID: 11458120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of bone marrow micrometastases with sentinel lymph node status in early-stage breast cancer.
    Saha S; Ali S; Ghanem M; Soni M; Wiese D; Arora M; Singh T; Iddings D
    Ann Surg Oncol; 2009 Feb; 16(2):276-80. PubMed ID: 19050967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.